Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06439979 · ClinicalTrials.gov registry record · NA
Rural Adult and Youth Sun Protection Study
A NA study of Melanoma (Skin) and Skin Cancer, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 843
- Enrollment target
- 2
- Study locations
NCT06439979 is a NA study of Melanoma (Skin) and Skin Cancer that is actively recruiting participants, run by University of Utah. The registered enrollment target is 843 participants, above the 109-participant average among 30 other Melanoma (Skin) trials with a reported enrollment target (673% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06439979, a NA study of Melanoma (Skin) and Skin Cancer, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 843 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to help prevent skin cancer by improving the use of sun protective behaviors among youths living in rural communities in Utah and West Virginia.
Conditions Studied
Interventions
- BEHAVIORAL RAYS Intervention
Study Locations (2)
Utah
- University of Utah - Salt Lake City
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 843 participants |
| Start Date | 2024-04-08 |
| Est. Completion | 2030-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06439979
The ClinicalTrials.gov registry entry for NCT06439979 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 843 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 109-participant average among 30 other Melanoma (Skin) trials with a reported enrollment target (673% higher). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Melanoma (Skin) appearing as the primary indexed condition, and to 1 intervention - of which RAYS Intervention is the first listed.
NCT06439979 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Utah, West Virginia.
Frequently Asked Questions
What is clinical trial NCT06439979 about?
NCT06439979 is a clinical study titled "Rural Adult and Youth Sun Protection Study". The purpose of this study is to help prevent skin cancer by improving the use of sun protective behaviors among youths living in rural communities in Utah and West Virginia.
What is the current status of trial NCT06439979?
This trial is currently recruiting. It is a NA study. The enrollment target is 843 participants. The study started on 2024-04-08. Estimated completion is 2030-04.
What conditions does trial NCT06439979 study?
This clinical trial studies the following conditions: Melanoma (Skin), Skin Cancer.
What interventions are being tested in trial NCT06439979?
The interventions under investigation include: RAYS Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06439979?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06439979 being conducted?
This trial has 2 study locations across Utah, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma (Skin)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
RECRUITING · NA
-
DermaSensor Postmarket Surveillance Study
RECRUITING · NA
-
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
RECRUITING · Phase 2
-
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
RECRUITING · Phase 1
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
RECRUITING
-
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.